Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,500
+160 (1.55%)
At close: Dec 5, 2025

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 244.20 billion as of December 5, 2025. Its market cap has decreased by -16.31% in one year.

Market Cap
244.20B
Enterprise Value
206.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10,500.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 244.20B, an increase of 52.40%. That is a compound annual growth rate of 8.43%.

History

DateMarket Cap% Change
Dec 5, 2025244.20B1.83%
Dec 30, 2024239.82B-53.54%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 20202,517.20B1,470.89%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition